Millennium Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Millennium Management’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-69,000	Closed	-$12.2M	–	7556
2021 Q3	$12.2M	Buy	+69,000	New	+$11.1M	0.01%	1814
2021 Q2	–	Sell	-10,000	Closed	-$1.71M	–	7290
2021 Q1	$1.71M	Buy	10,000 +6,000	+150%	+$1.19M	﹤0.01%	3681
2020 Q4	$879K	Buy	+4,000	New	+$865K	﹤0.01%	3819
2019 Q4	–	Sell	-135,000	Closed	-$10.5M	–	4730
2019 Q3	$10.5M	Buy	+135,000	New	+$12.7M	0.02%	1250
2019 Q2	–	Sell	-150,000	Closed	-$11M	–	4589
2019 Q1	$11M	Buy	+150,000	New	+$10.2M	0.02%	1184
2018 Q4	–	Sell	-100,000	Closed	-$4.71M	–	4292
2018 Q3	$4.71M	Buy	+100,000	New	+$5.57M	0.01%	1847
2018 Q2	–	Sell	-25,000	Closed	-$768K	–	4283
2018 Q1	$768K	Buy	+25,000	New	+$694K	﹤0.01%	2829

Other funds holding MRTX

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Millennium Management's MRTX Position: Q1 2024 in Review

Millennium Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 58,626 shares — an estimated $3.44M sold.

Millennium Management first reported a position in MRTX in Q3 2015 and held it in 29 quarters. The position peaked at $79.5M in Q2 2021. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

Millennium Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Millennium Management sold 58,626 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $3.44M.
Millennium Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2015 and held it in 29 quarters.
Millennium Management's Mirati Therapeutics, Inc. Common Stock position peaked at $79.5M in Q2 2021.
2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.